Novo Nordisk | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
ANI Pharmaceuticals USD 149.8M 4.94M 2025-03
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bausch Health Companies USD 1.13B 47M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 89.82M 37.85M 2025-03
Drreddys Laboratories INR 1.1B 743M 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Merck USD 8.63B 4.61B 2025-03
Novartis USD 8.87B 4.74B 2024-12
Novo Nordisk 57.02B 4.2B 2024-09
Pacira USD 283.61M 6.84M 2025-03
Perrigo USD 409.9M 148.9M 2025-03
Prestige Brands USD 97.88M 47.01M 2025-03
Sanofi 7.99B 550M 2025-03
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Zoetis USD 1.72B 264M 2025-03



Novo Nordisk Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.